siRNA therapy decreases triglycerides in patients with uncommon health condition

.STUDY EMPHASIZE.19 September 2024.

Plozasiran minimized triglyceride degrees through 80% and lowered the danger of pancreatitis in clients along with persistent chylomicronemia, along with or without a hereditary prognosis.